ATryn
- Product NDC
- 42976-121
- 11-digit product format
- 429760121
- Labeler code
- 42976
- Product ID
- 42976-121_634fb454-4f7f-4b30-9f89-fd3a122cf074
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Antithrombin Recombinant
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- rEVO Biologics, Inc.
- Application
- BLA125284
- Marketing category
- BLA
- Marketing start
- 2009-05-06
- Marketing end
- 0000-00-00
- Substance
- ANTITHROMBIN ALFA
- Active strength
- 1750 [iU]/mL
- Pharmacologic classes
- Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA],Recombinant Antithrombin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42976-121-02 | 42976012102 | 1 VIAL in 1 CARTON (42976-121-02) > 3 mL in 1 VIAL | 1 vial | 2009-05-06 | 0000-00-00 | No | No | Current |